Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
11.06.24
Read more
We are leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors. Using an approach that starts and ends with patients, we’re expanding the reach of genetically targeted therapies.